TechGuru , for sure 100% will not be taking Leronlimab , but I believe as education is spreading , more and more will ...

I hope that HIV positive patients will forget what happened in the past with Martin S , when he increased price for Daraprim such a dramatic way..

This drug Daraprim is for Toxoplasmosis , rare parasitic infection we see more often in HIV positive patients.
So this group of patients was affected by this the most ..

Hopefully patients will look at this company as a different company and evaluate at this point value of Leronlimab only..

Again IMO , education is everything here ...